ChemicalBook > Articles Catagory List >Organic-reagents >n-n-dimethylacetamide-preparation-introduction-and-uses

N,N-Dimethylacetamide: Preparation, Introduction, and uses

Apr 19，2024

Introduction

N, N-Dimethylacetamide is a colorless, water-miscible solvent used to synthesize vinyl resins, styrenes, and linear polyesters. Jaundice has been seen in people repeatedly exposed to small amounts of the solvent. Fatty infiltration in rats and focal necrosis in dogs have been observed after high-dose experimental exposure.

The organic, organometallic, and bioorganic transformations are extensively carried out in N, N-dimethylformamide (DMF) or N, N-dimethylacetamide (DMAc). These two polar solvents are used for their dissolution properties and as multipurpose reagents. They participate in several processes and serve as a source of various building blocks, giving one or more of their own atoms.

Article illustration

Preparation

N, N-Dimethylacetamide is prepared by the reaction of dimethylamine with acetic acid, acetic anhydride, or acetate esters. Heating dimethylamine acetate with or without a catalyst affords N, N-Dimethylacetamide. The reaction of dimethylamine with acetate esters requires a catalyst; sodium methoxide is typically used.

Uses

DMAc is used as a solvent for producing fibers and synthesizing organic compounds, notably pharmaceuticals. Its broad range of miscibility makes it useful in mixed solvents. It is also stable to strong bases but hydrolyzes in the presence of acids. As the hazard information table shows, it must be handled with care.

Toxicity

Multiple case reports have documented DMAC-associated hepatotoxicity, mainly in synthetic fiber workers. Acute DMAC poisoning is primarily manifested as a neuropsychiatric illness, including psychosis, delirium, and seizures, and as a systemic disease, including acute hepatitis. The primary route of exposure appears to be dermal absorption of DMAC vapor. Subclinical ALT elevations appear not infrequently in new synthetic fiber workers (within the first 7 months of employment) in a dose-dependent fashion. The elevation in ALT improved by 50% within 30 days in 90% of persons after DMAC exposure was halted. Interestingly, transaminitis appears to occur much less frequently, if at all, in workers exposed longer than 7 months, thus suggesting adaptation to chronic exposure. However, animal models have documented liver injury following both acute and chronic DMF exposure.

References

[1] Jean Le Bras, Jacques Muzart. “Recent Uses of N,N-Dimethylformamide and N,N-Dimethylacetamide as Reagents.” Molecules 23 8 (2018).

[2] Schiano, T. and Kristel H. Hunt. “Chapter 28 – Occupational and Environmental Hepatotoxicity.”Drug-Induced Liver Disease (Third Edition) 2013: 659-675.

);